SA
Go ProLog In
SGMO
OverviewIntelligenceChart
Q3 2026 EPS Estimate
$-0.04
Revenue Estimate
$11M

Analyst Sentiment

Wall St. Consensus
Hold
13 analysts·Moderate coverage
60
Score
6 Buy (46%)6 Hold (46%)1 Sell (8%)
Rating Breakdown
Strong Buy
00%
Buy
646%
Hold
646%
Sell
18%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
+1076.5%
Consensus
$4.00
+2252.9%
Bull
$19.00
+11076.5%
12-Month Target Range13 analysts
$2.00$4.00$19.00
Current $0.17Consensus
Current Price
$0.17
Upside to Consensus
$3.83

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Recent Analyst Actions

Dec 31, 2024Jefferies
Sangamo price target lowered to $3 from $7 at Jefferies
Target:$3.00
+194.1%from $1.02
Dec 31, 2024Wells Fargo
Sangamo price target lowered to $2 from $3 at Wells Fargo
Target:$2.00
+96.1%from $1.02
Jun 13, 2022Wedbush
Sangamo assumed with a Neutral at Wedbush
Target:$5.00
+33.0%from $3.76
Apr 5, 2022Truist Financial
Sangamo BioSciences (SGMO) Stock: Why The Price Increased
Target:$19.00
+208.9%from $6.15

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance